Tag: trial
Source: Dr. Yi Chen (9/17/22) The purpose behind this complementary study is to potentially expand the treatment’s target patient population, noted an H.C. Wainwright & Co. report. ASLAN Pharmaceuticals Ltd. (ASLN:NASDAQ), to complement its in-progress TREK-AD dose-ranging eblasakimab trial for moderate to severe atopic dermatitis (eczema), plans a second study, TREK-DX, in the subpopulation of patients […]
Among individuals taking the medication with standard-of-care topical corticosteroids, approximately 41% achieved clear or almost clear skin at 16 weeks. Approximately 70% of individuals with moderate-to-severe atopic dermatitis (AD) receiving lebrikizumab combined with standard-of-care topical corticosteroids (TCS) achieved at least a 75% improvement in overall disease severity in the ADhere trial at 16 weeks, Eli […]